Question 1

What does the CA125 test involve, and how might it affect my follow-up care?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125 clinical trial (NCT03004391). Contact the study team or your healthcare provider for specific answers.

Question 2

How will this decision aid help me make my choice regarding the CA125 test?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125 clinical trial (NCT03004391). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential benefits and risks of including the CA125 test in my monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125 clinical trial (NCT03004391). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my decision be documented and communicated to my healthcare team?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125 clinical trial (NCT03004391). Contact the study team or your healthcare provider for specific answers.

Question 5

What support will I receive during the decision-making process?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Development of a Decision Aid to Facilitate Ovarian Cancer Patient's Choices Regarding Biomarker CA125 clinical trial (NCT03004391). Contact the study team or your healthcare provider for specific answers.

What this study is about